James Shepherd

1.3k total citations · 1 hit paper
19 papers, 699 citations indexed

About

James Shepherd is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, James Shepherd has authored 19 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in James Shepherd's work include Tuberculosis Research and Epidemiology (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and HIV Research and Treatment (4 papers). James Shepherd is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and HIV Research and Treatment (4 papers). James Shepherd collaborates with scholars based in United States, United Kingdom and Uganda. James Shepherd's co-authors include Christopher J. Packard, Muriel Caslake, Bruce A. Griffin, J. D. Thomson, Graeme W. Tait, Dilys J. Freeman, Ronald H. Gray, Godfrey Kigozi, Noah Kiwanuka and David Serwadda and has published in prestigious journals such as Environmental Science & Technology, Clinical Infectious Diseases and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

James Shepherd

18 papers receiving 673 citations

Hit Papers

Role of plasma triglyceride in the regulation of plasma l... 1994 2026 2004 2015 1994 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk
    1994 457 citations Bruce A. Griffin, Dilys J. Freeman et al. Atherosclerosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Shepherd United States 8 339 337 152 152 123 19 699
Craig A. Sponseller United States 15 379 1.1× 207 0.6× 170 1.1× 137 0.9× 112 0.9× 33 750
Clement Maurath United States 11 201 0.6× 115 0.3× 83 0.5× 377 2.5× 248 2.0× 14 1.3k
Boris Kerzner United States 10 491 1.4× 244 0.7× 201 1.3× 24 0.2× 112 0.9× 11 878
Timothy C. Hardman United Kingdom 14 130 0.4× 150 0.4× 62 0.4× 63 0.4× 54 0.4× 60 621
Lisa A. Kosmiski United States 16 88 0.3× 149 0.4× 152 1.0× 217 1.4× 66 0.5× 29 789
S B Hulley United States 8 172 0.5× 102 0.3× 61 0.4× 55 0.4× 70 0.6× 10 375
Robert C. Stevens United States 14 79 0.2× 356 1.1× 239 1.6× 116 0.8× 33 0.3× 25 975
Kimberly Wong United States 12 74 0.2× 128 0.4× 183 1.2× 78 0.5× 65 0.5× 17 695
E Fassio Argentina 21 336 1.0× 333 1.0× 1.2k 7.6× 81 0.5× 98 0.8× 45 1.5k
Mustafa A. Noor United States 14 107 0.3× 250 0.7× 208 1.4× 900 5.9× 63 0.5× 20 1.6k

Countries citing papers authored by James Shepherd

Since Specialization
Citations

This map shows the geographic impact of James Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Shepherd more than expected).

Fields of papers citing papers by James Shepherd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Shepherd. The network helps show where James Shepherd may publish in the future.

Co-authorship network of co-authors of James Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of James Shepherd. A scholar is included among the top collaborators of James Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Shepherd. James Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zulli, Alessandro, et al.. (2025). Utilizing Internet Search Trends and Wastewater Surveillance to Identify Infectious Disease Outbreaks in Communities. Environmental Science & Technology. 59(7). 3401–3410. 1 indexed citations
2.
3.
Click, Eleanor S., Alyssa Finlay, John E. Oeltmann, et al.. (2020). Phylogenetic diversity of Mycobacterium tuberculosis in two geographically distinct locations in Botswana – The Kopanyo Study. Infection Genetics and Evolution. 81. 104232–104232. 7 indexed citations
4.
Shepherd, James & Gerald Friedland. (2020). Preventing COVID-19 Collateral Damage. Clinical Infectious Diseases. 71(6). 1564–1567. 4 indexed citations
5.
6.
Kunkel, Amber, Forrest W. Crawford, James Shepherd, & Ted Cohen. (2016). Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS. 30(17). 2715–2723. 13 indexed citations
7.
Samandari, Taraz, Tefera Agizew, Samba Nyirenda, et al.. (2015). Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana. 1 indexed citations
8.
Samandari, Taraz, Tefera Agizew, Samba Nyirenda, et al.. (2014). Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana. AIDS. 29(3). 351–359. 33 indexed citations
9.
Shepherd, James, Rebecca G. Nowak, Man Charurat, et al.. (2012). Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. AIDS. 27(4). 553–561. 23 indexed citations
10.
Kiwanuka, Noah, Oliver Laeyendecker, Thomas C. Quinn, et al.. (2009). HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS. 23(18). 2479–2484. 70 indexed citations
11.
Shepherd, James. (2005). Special report: highlights of the 75th European Atherosclerosis Society congress. Atherosclerosis. 181(2). S1–S7. 4 indexed citations
12.
Shepherd, James. (2004). Reduced Transmission of HIV-1 Subtype D Compared With Subtype A in Rakai, Uganda.. 3 indexed citations
13.
Sattar, Naveed, et al.. (1997). Lipoprotein Subfraction Concentrations in Preeclampsia. Obstetrical & Gynecological Survey. 89(3). 403–408. 3 indexed citations
14.
Gaw, Allan, Christopher J. Packard, Grace Lindsay, et al.. (1996). Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism. Arteriosclerosis Thrombosis and Vascular Biology. 16(2). 236–249. 22 indexed citations
15.
Shepherd, James. (1994). Lipoprotein Metabolism. Drugs. 47(Supplement 2). 1–10. 32 indexed citations
16.
Griffin, Bruce A., Dilys J. Freeman, Graeme W. Tait, et al.. (1994). Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 106(2). 241–253. 457 indexed citations breakdown →
17.
Bedford, Dorothy, et al.. (1993). An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosa. Lipids. 28(11). 995–998. 7 indexed citations
18.
Gaw, Allan, Christopher J. Packard, & James Shepherd. (1992). VLDL and LDL turnover: methods and clinical application. Current Opinion in Lipidology. 3(6). 384–388. 5 indexed citations
19.
Packard, Christopher J., et al.. (1976). Low-Density-Lipoprotein Metabolism in Type n Hyperlipoproteinaemia. Biochemical Society Transactions. 4(1). 105–107. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig A. Sponseller Breakdown of academic impact, for papers by Clement Maurath Breakdown of academic impact, for papers by Boris Kerzner Breakdown of academic impact, for papers by Timothy C. Hardman Breakdown of academic impact, for papers by Lisa A. Kosmiski Breakdown of academic impact, for papers by S B Hulley Breakdown of academic impact, for papers by Robert C. Stevens Breakdown of academic impact, for papers by Kimberly Wong Breakdown of academic impact, for papers by E Fassio Breakdown of academic impact, for papers by Mustafa A. Noor
Rankless by CCL
2026